Citation Impact
Citing Papers
Decreased Clearance of CNS β-Amyloid in Alzheimer’s Disease
2010 StandoutScience
mTOR-Dependent Synapse Formation Underlies the Rapid Antidepressant Effects of NMDA Antagonists
2010 StandoutScience
FMRP targets distinct mRNA sequence elements to regulate protein expression
2012 Nature
Reduction of Brain β-Amyloid (Aβ) by Fluvastatin, a Hydroxymethylglutaryl-CoA Reductase Inhibitor, through Increase in Degradation of Amyloid Precursor Protein C-terminal Fragments (APP-CTFs) and Aβ Clearance
2010
Ribosome Profiling of Mouse Embryonic Stem Cells Reveals the Complexity and Dynamics of Mammalian Proteomes
2011 Standout
3-Hydroxy-3-Methylglutaryl-Coenzyme A Reductase Inhibitors Attenuate β-Amyloid-Induced Microglial Inflammatory Responses
2005
Cholesterol and the Biology of Alzheimer's Disease
2004
The translation of translational control by FMRP: therapeutic targets for FXS
2013
Microglia-mediated neurotoxicity: uncovering the molecular mechanisms
2006 Standout
Microarray Analysis in Alzheimer's Disease and Normal Aging
2004
Advances in metal-induced oxidative stress and human disease
2011 Standout
Oxidative stress, dysfunctional glucose metabolism and Alzheimer disease
2019 Standout
mTOR signaling: At the crossroads of plasticity, memory and disease
2009
Microglial activation in the hippocampus of hypercholesterolemic rabbits occurs independent of increased amyloid production
2007
Rapamycin: One Drug, Many Effects
2014 Standout
Rapamycin reverses impaired social interaction in mouse models of tuberous sclerosis complex
2012
A METTL3–METTL14 complex mediates mammalian nuclear RNA N6-adenosine methylation
2013 Standout
Effects of stress throughout the lifespan on the brain, behaviour and cognition
2009 Standout
TRIBE: Hijacking an RNA-Editing Enzyme to Identify Cell-Specific Targets of RNA-Binding Proteins
2016 StandoutNobel
mTOR at the nexus of nutrition, growth, ageing and disease
2020 Standout
Differential Roles of M1 and M2 Microglia in Neurodegenerative Diseases
2015 Standout
FMRP Stalls Ribosomal Translocation on mRNAs Linked to Synaptic Function and Autism
2011 Standout
Measuring reactive species and oxidative damagein vivoand in cell culture: how should you do it and what do the results mean?
2004 Standout
Copper in the brain and Alzheimer’s disease
2009
mTOR Signaling in Growth, Metabolism, and Disease
2017 Standout
Biliverdin reductase‐A: a novel drug target for atorvastatin in a dog pre‐clinical model of Alzheimer disease
2011
The Effect of Simvastatin Treatment on the Amyloid Precursor Protein and Brain Cholesterol Metabolism in Patients with Alzheimer’s Disease
2005
Neurovascular regulation in the normal brain and in Alzheimer's disease
2004 Standout
Neocortical excitation/inhibition balance in information processing and social dysfunction
2011 StandoutNature
Widespread Translational Remodeling during Human Neuronal Differentiation
2017 StandoutNobel
Hypersensitivity to mGluR5 and ERK1/2 Leads to Excessive Protein Synthesis in the Hippocampus of a Mouse Model of Fragile X Syndrome
2010
The Role of Short-Chain Fatty Acids From Gut Microbiota in Gut-Brain Communication
2020 Standout
Power failure: why small sample size undermines the reliability of neuroscience
2013 Standout
Modeling Autistic Features in Animals
2011
A New Glucocorticoid Hypothesis of Brain Aging: Implications for Alzheimers Disease
2007
Iron, Atherosclerosis, and Neurodegeneration: A Key Role for Cholesterol in Promoting Iron‐Dependent Oxidative Damage?
2004
Alzheimer's disease
2006 Standout
The Neurology of mTOR
2014
Behavioural study of the -galactose induced aging model in C57BL/6J mice
2004 Standout
Where, When, and How: Context-Dependent Functions of RNA Methylation Writers, Readers, and Erasers
2019 Standout
Modulation of Statin-Activated Shedding of Alzheimer APP Ectodomain by ROCK
2005
Alzheimer's Disease
2010 Standout
Metal Toxicity Links to Alzheimer's Disease and Neuroinflammation
2019
An RNA-centric dissection of host complexes controlling flavivirus infection
2019 StandoutNobel
AKT/PKB Signaling: Navigating the Network
2017 Standout
A recollection of mTOR signaling in learning and memory
2013
Alzheimer's Disease
2004 Standout
Oxidative stress and neurodegeneration: where are we now?
2006 Standout
Statins: drugs for Alzheimer’s disease?
2005
The ACAT Inhibitor CP-113,818 Markedly Reduces Amyloid Pathology in a Mouse Model of Alzheimer's Disease
2004
Signals, synapses, and synthesis: how new proteins control plasticity
2009
The amyloid state and its association with protein misfolding diseases
2014 Standout
Neurovascular pathways to neurodegeneration in Alzheimer's disease and other disorders
2011 Standout
Increased App Expression in a Mouse Model of Down's Syndrome Disrupts NGF Transport and Causes Cholinergic Neuron Degeneration
2006 Standout
Hepatitis C Virus RNA Functionally Sequesters miR-122
2015 StandoutNobel
Comprehensive Review on Alzheimer’s Disease: Causes and Treatment
2020 Standout
Evolution of the human lifespan and diseases of aging: Roles of infection, inflammation, and nutrition
2009
Copper in Alzheimer's Disease: A Meta-Analysis of Serum, Plasma, and Cerebrospinal Fluid Studies
2011
Incipient Alzheimer's disease: Microarray correlation analyses reveal major transcriptional and tumor suppressor responses
2004
An epigenetic biomarker of aging for lifespan and healthspan
2018 Standout
Tunable protein synthesis by transcript isoforms in human cells
2016 StandoutNobel
Translational Control in Synaptic Plasticity and Cognitive Dysfunction
2014
Physiology of Microglia
2011 Standout
The Connectivity Map: Using Gene-Expression Signatures to Connect Small Molecules, Genes, and Disease
2006 StandoutScience
Gene Microarrays in Hippocampal Aging: Statistical Profiling Identifies Novel Processes Correlated with Cognitive Impairment
2003
Works of Ali Sharma being referenced
Dysregulation of mTOR Signaling in Fragile X Syndrome
2010
Changes in Apolipoprotein E Expression in Response to Dietary and Pharmacological Modulation of Cholesterol
2003
Statin therapy for Alzheimer’s disease
2002
Trace copper levels in the drinking water, but not zinc or aluminum influence CNS Alzheimer-like pathology.
2006